Pages that link to "Q44495812"
Jump to navigation
Jump to search
The following pages link to 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial (Q44495812):
Displaying 50 items.
- Low dose versus high dose stavudine for treating people with HIV infection (Q24186488) (← links)
- Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design (Q28369425) (← links)
- Homologues of isomeric dideoxynucleosides as potential antiviral agents: synthesis of isodideoxynucleosides with a furanethanol sugar moiety (Q28375823) (← links)
- An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine (Q28379270) (← links)
- Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy (Q28478110) (← links)
- Temporal development of 2',3'-dideoxyinosine (ddI)-induced peripheral myelinopathy (Q31391473) (← links)
- Effect of food on the bioavailability of stavudine in subjects with human immunodeficiency virus infection (Q33696676) (← links)
- Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides (Q33757004) (← links)
- Stavudine: an update of its use in the treatment of HIV infection (Q33793229) (← links)
- Development and optimization of anti-HIV nucleoside analogs and prodrugs: A review of their cellular pharmacology, structure-activity relationships and pharmacokinetics (Q33933498) (← links)
- Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells (Q33978880) (← links)
- Determination of dosing guidelines for stavudine (2',3'-didehydro-3'-deoxythymidine) in children with human immunodeficiency virus infection (Q33981606) (← links)
- Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity (Q34023081) (← links)
- Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors (Q34282667) (← links)
- A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand (Q34308783) (← links)
- AIDS and AIDS-treatment neuropathies (Q34548429) (← links)
- Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B (Q34591879) (← links)
- Tolerabilities of antiretrovirals in paediatric HIV infection. (Q34984835) (← links)
- Nucleoside analogues and neuropathy in the era of HAART. (Q35071456) (← links)
- Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex (Q35119768) (← links)
- Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina). (Q35121223) (← links)
- Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma. (Q35125037) (← links)
- Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina) (Q35128529) (← links)
- Hyperlactataemia syndromes associated with HIV therapy (Q35143082) (← links)
- Antiretroviral-associated liver injury (Q35184579) (← links)
- Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. (Q36403417) (← links)
- Current clinical treatments of AIDS. (Q37034589) (← links)
- Pharmacologic consideration for the use of antiretroviral agents in the elderly (Q37277510) (← links)
- A review of the toxicity of HIV medications (Q37633495) (← links)
- Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity (Q37734538) (← links)
- Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA (Q37798546) (← links)
- HIV-associated sensory neuropathy: risk factors and genetics (Q37988382) (← links)
- Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro (Q39784283) (← links)
- HIV neuropathy in South Africans: frequency, characteristics, and risk factors (Q39924073) (← links)
- Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker (Q40045544) (← links)
- Pharmacokinetic Optimisation of Antiretroviral Therapy in Patients with HIV Infection (Q40430974) (← links)
- Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. (Q40447292) (← links)
- Synthesis and anti-HIV activity of some [Nucleoside Reverse Transcriptase Inhibitor]-C5'-linker-[Integrase Inhibitor] heterodimers as inhibitors of HIV replication. (Q40468069) (← links)
- Present Status and Future Prospects for HIV Therapies (Q40486948) (← links)
- Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors. (Q40745355) (← links)
- Lamivudine (3TC) phosphorylation and drug interactions in vitro (Q40880707) (← links)
- Primary care of the HIV patient: standard practice and new developments in the era of managed care (Q40977715) (← links)
- Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation (Q40983879) (← links)
- Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection (Q41155364) (← links)
- Treatment of HIV infection. Tolerability of commonly used antiretroviral agents (Q41175137) (← links)
- Neurologic manifestations of HIV infection. (Q41240954) (← links)
- Clinical Pharmacokinetics of Stavudine (Q41619569) (← links)
- Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions (Q41729315) (← links)
- Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients (Q41898084) (← links)
- Baicalin, an inhibitor of HIV-1 production in vitro (Q42542425) (← links)